Cancer News
Big Plans: ASCO Targets Obesity-Cancer Link

New Standard in Melanoma: Combo of BRAF and MEK Inhibitors

Oncologist Sentenced to 10 Years for Poisoning Colleague

The Value of Multiplex Genotyping for Lung Cancer

'Impressive' Duration of Response With Nivolumab in Melanoma
Thyroid cancer: additional new subgroup analyses for Phase III SELECT trial

Immunotherapy could stop resistance to radiotherapy

Study: tumor BRACAnalysis CDx identifies 44 percent more candidates for PARP therapy

New imaging technique could revolutionise how children with neuroblastoma are diagnosed and treated

Targeted treatment could halt womb cancer growth
Herceptin Best for Certain Breast Cancer Patients, Study Says

Scientists Detect Early Sign of Pancreatic Cancer

Increasing Skirt Sizes May Hike Your Breast Cancer Risk: Study

Lung Infections May Hamper Ability to Detect Lung Cancer

FDA Warns Doctors of Danger From Fake Drugs
Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect

UCLA Scientists Discover Protein that Can Potentially Accelerate Recovery in Cancer Patients Following Radiation and Chemotherapy

Special Recognition for Jonsson Comprehensive Cancer Center at Avon Walk for Breast Cancer

FDA Approves Game-Changing Melanoma Drug that Turns on Immune System to Fight Deadly Cancers

Vault Nanoparticles Engineered at UCLA Show Promise for Cancer Treatment
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate cancer trial

Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors in patients with advanced solid tumors

Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: The GEMCAD 0801 Phase II Multicenter Trial

The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: An analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years